Kristin Hurley

Bioanalytical Manager at Dicerna Pharmaceuticals, Inc. - Lexington, Massachusetts, US

Kristin Hurley's Colleagues at Dicerna Pharmaceuticals, Inc.
Adam Hirsh

Quality Change Control & Document Control Manager

Contact Adam Hirsh

Jing Yu

Senior Manager, Statistical programmer

Contact Jing Yu

Patti G

Administrative Consultant

Contact Patti G

Ricardo Jr.

ADME Outsource Manager

Contact Ricardo Jr.

View All Kristin Hurley's Colleagues
Kristin Hurley's Contact Details
HQ
(617) 621-8097
Location
Company
Dicerna Pharmaceuticals, Inc.
Kristin Hurley's Company Details
Dicerna Pharmaceuticals, Inc. logo, Dicerna Pharmaceuticals, Inc. contact details

Dicerna Pharmaceuticals, Inc.

Lexington, Massachusetts, US • 500 - 999 Employees
Major Drugs

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease. Using our proprietary GalXC™ and GalXC-Plus™ RNAi technologies, we discover and develop innovative RNAi-based therapies with the potential to treat both rare and more prevalent diseases. By silencing disease-causing genes, our GalXC platform has the potential to address conditions that are difficult to treat with other modalities. Initially focused on disease-causing genes in the liver, we have continued to innovate and are exploring new applications of our RNAi technology with GalXC-Plus, which expands on the functionality and application of our flagship liver-targeted GalXC technology to tissues and cell types outside the liver with the potential to treat diseases across multiple therapeutic areas. Our team brings together talented experts across the fields of biology, chemistry, clinical science, medicine and more. With decades of scientific and technical experience focused on RNAi technology, we have the knowledge and experience needed to discover and develop therapies for patients with serious unmet medical needs. Between our own pipeline of core discovery and clinical candidates and those developed through collaborative relationships with some of the world’s leading pharmaceutical companies, we have generated more than 20 active discovery, preclinical or clinical proprietary and collaborative programs focused on rare, cardiometabolic, viral, chronic liver and complement-mediated diseases, as well as neurodegenerative diseases and pain.

Targeted Cancer Therapies Rare Disease Neurodegenerative Diseases
Details about Dicerna Pharmaceuticals, Inc.
Frequently Asked Questions about Kristin Hurley
Kristin Hurley currently works for Dicerna Pharmaceuticals, Inc..
Kristin Hurley's role at Dicerna Pharmaceuticals, Inc. is Bioanalytical Manager.
Kristin Hurley's email address is ***@dicerna.com. To view Kristin Hurley's full email address, please signup to ConnectPlex.
Kristin Hurley works in the Major Drugs industry.
Kristin Hurley's colleagues at Dicerna Pharmaceuticals, Inc. are Adam Hirsh, Jing Yu, Tim Morrison, Hristina Atanasova, Patti G, Jonathan Lafrance, Ricardo Jr. and others.
Kristin Hurley's phone number is ["+15087355335"]
See more information about Kristin Hurley